Information  X 
Enter a valid email address

ReNeuron Group PLC Ord 1P (RENE)

Date Time Source Announcement
16 Jul 2019 7:00 am
RNS
Key patent grants expand exosome IP portfolio
12 Jul 2019 7:00 am
RNS
Senior business development appointment
11 Jul 2019 7:00 am
RNS
Preliminary Results
08 Jul 2019 4:30 pm
RNS
Notification of Major Holdings
01 Jul 2019 11:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Total Voting Rights
18 Jun 2019 4:01 pm
RNS
Notification of Major Holdings
  7:00 am
RNS
Webcast of Preliminary Results
14 Jun 2019 11:09 am
RNS
ReNeuron wins Breakthrough of the Year Award
03 Jun 2019 7:00 am
RNS
Total Voting Rights
31 May 2019 7:00 am
RNS
Jefferies 2019 Global Healthcare Conference
09 May 2019 5:05 pm
RNS
Exercise of options, PDMR dealing and TVR
08 May 2019 7:00 am
RNS
Year-end update and results notification
02 May 2019 3:43 pm
RNS
Total Voting Rights
26 Apr 2019 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Clinical update and conference presentation
18 Apr 2019 3:40 pm
RNS
Share Purchases by Directors
12 Apr 2019 2:36 pm
RNS
Exercise of Share Options and TVR
11 Apr 2019 4:31 pm
RNS
Share Purchases by Directors
10 Apr 2019 2:37 pm
RNS
Director/PDMR Shares and Share Options
09 Apr 2019 9:50 am
RNS
ReNeuron partners with Fosun Pharma in China
05 Apr 2019 7:00 am
RNS
ReNeuron to present at UK investor conference
04 Apr 2019 7:00 am
RNS
Clinical update and conference presentation
28 Mar 2019 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
18 Mar 2019 12:00 pm
RNS
Alliance for Regenerative Medicine presentation
  7:00 am
RNS
Retinal clinical trial progresses to next stage
12 Mar 2019 2:30 pm
RNS
Notification of Major Holdings
05 Mar 2019 12:56 pm
RNS
Notification of Major Holdings
  7:00 am
RNS
Notification of Major Holdings
  7:00 am
RNS
Notification of Major Holdings
28 Feb 2019 7:00 am
RNS
Block Listing Review and Total Voting Rights
20 Feb 2019 7:00 am
RNS
Positive preliminary data in US retinal trial
31 Jan 2019 7:00 am
RNS
New exosome production scale-up data presented
24 Jan 2019 7:00 am
RNS
First patient treated in US stroke trial
04 Jan 2019 7:00 am
RNS
ReNeuron signs exosome collaboration
14 Dec 2018 7:00 am
RNS
Interim Results
20 Nov 2018 2:00 pm
RNS
Notification of Interim Results
18 Oct 2018 7:00 am
RNS
ReNeuron's lead cell line shows further potential
28 Sep 2018 2:16 pm
RNS
Director/PDMR Interest in Shares and Share Options
27 Sep 2018 3:02 pm
RNS
Directors Share Purchases
19 Sep 2018 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Business development update
12 Sep 2018 11:40 am
RNS
Result of AGM
  7:00 am
RNS
AGM Trading Update
31 Aug 2018 7:00 am
RNS
Block Listing Review and TVR
31 Jul 2018 3:25 pm
RNS
Posting of Annual Report & Notice of AGM
17 Jul 2018 7:00 am
RNS
Notification of Major Holdings
  7:00 am
RNS
Notification of Major Holdings
16 Jul 2018 3:39 pm
RNS
Notification of Major Holdings
  7:00 am
RNS
Notification of Major Holdings
  7:00 am
RNS
Notification of Major Holdings
13 Jul 2018 11:50 am
RNS
Notification of Major Holdings
  11:50 am
RNS
Notification of Major Holdings
12 Jul 2018 7:00 am
RNS
Preliminary Results
11 Jul 2018 7:00 am
RNS
Signs retinal stem cell exclusivity agreement
04 Jul 2018 2:15 pm
RNS
Notification of Preliminary Results
17 May 2018 7:00 am
RNS
Capital Markets Event
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t